David J. Main
2017
In 2017, David J. Main earned a total compensation of $3M as Chief Executive Officer and President at Aquinox Pharmaceuticals, a 131% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $240,975 |
|---|---|
| Option Awards | $2,289,339 |
| Salary | $510,000 |
| Total | $3,040,314 |
Main received $2.3M in option awards, accounting for 75% of the total pay in 2017.
Main also received $241K in non-equity incentive plan and $510K in salary.
Rankings
In 2017, David J. Main's compensation ranked 3,584th out of 14,666 executives tracked by ExecPay. In other words, Main earned more than 75.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,584 out of 14,666 | 76th |
Division Manufacturing | 1,237 out of 5,768 | 79th |
Major group Chemicals And Allied Products | 346 out of 2,074 | 83rd |
Industry group Drugs | 267 out of 1,730 | 85th |
Industry Pharmaceutical Preparations | 211 out of 1,329 | 84th |
Source: SEC filing on March 26, 2018.
Main's colleagues
We found two more compensation records of executives who worked with David J. Main at Aquinox Pharmaceuticals in 2017.